Italia markets closed

BMY Apr 2024 54.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,01000,0000 (0,00%)
Alla chiusura: 03:42PM EDT
Schermo intero
Chiusura precedente0,0100
Aperto0,0400
Denaro0,0000
Lettera0,0100
Prezzo d'esercizio54,00
Scadenza2024-04-26
Min-Max giorno0,0100 - 0,0400
Contratto - Min-MaxN/D
Volume2
Open Interest1,14k
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri